Atlas Trials

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

Clinical trial NCT06543966 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06543966
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Post-operative Nausea and Vomiting (PONV)
Start date
2024-10-28
Primary completion
2026-03-28
Enrollment
486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.